These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8614961)

  • 1. Interviews of individuals diagnosed as anti-human immunodeficiency virus-positive through the screening of blood donations in the Paris area to 1994: reflections on the selection of blood donors.
    Lefrere JJ; Elghouzzi MH; Salpetrier J; Duc A; Dupuy-Montbrun MC
    Transfusion; 1996 Feb; 36(2):124-7. PubMed ID: 8614961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interviews with anti-HIV-positive individuals detected through the systematic screening of blood donations: consequences on predonation medical interview.
    Lefrère JJ; Elghouzzi MH; Paquez F; N'Dalla J; Nubel L
    Vox Sang; 1992; 62(1):25-8. PubMed ID: 1580063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interviews with HIV seropositive subjects identified at the time of blood donation: consequences for pre-donation interviews].
    Lefrere JJ; Paquez F; Duc A; Rouger P; Salmon C
    Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):239-48. PubMed ID: 2222656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for HIV seropositivity among first-time blood donors in Zimbabwe.
    McFarland W; Mvere D; Shamu R; Katzenstein D
    Transfusion; 1998 Mar; 38(3):279-84. PubMed ID: 9563408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
    Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
    AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
    Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG
    N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
    Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
    Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to reduce the prevalence of HIV-positive blood donors].
    León G; Hernández T; Quiros AM; Maio A; García L
    Invest Clin; 1998 Dec; 39(4):307-21. PubMed ID: 9927804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group.
    Busch MP; Operskalski EA; Mosley JW; Stevens CE; Schiff ER; Kleinman SH; Lee H; Lee M; Harris M
    Transfusion; 1994 Oct; 34(10):858-64. PubMed ID: 7940656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1-infected blood donors: epidemiologic, laboratory, and donation characteristics. The HIV Blood Donor Study Group.
    Petersen LR; Doll LS
    Transfusion; 1991 Oct; 31(8):698-703. PubMed ID: 1926312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
    León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
    Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of blood donation history of people with HIV infection to identify recipients at risk.
    Gill MJ; Meyers G; Rajwani A
    CMAJ; 1994 Oct; 151(8):1147-51. PubMed ID: 7922946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.